Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Biogen Inc. Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Biogen Inc. stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 29,721 shares of BIIB stock, worth $5.26 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
29,721Holding current value
$5.26 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.94 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.89 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.57 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.26 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...